Day 4 Biopsy Improves Pregnancy Outcome Comparing to Day 3 Biopsy in Preimplantation Genetic ScreeningEun-Kyung Kim1, Eun-Ah Kim1, Eun-Ha Kim1, Nam-Hyung Kim2, Dong-Hee Choi1,3 and Hwang Kwon1,3*
- *Corresponding Author:
- Hwang Kwon
Fertility Center, CHA Bundang Medical Center
CHA University, Seongnam-si, 463-712, Korea
E-mail: [email protected]
Received date: September 02, 2015; Accepted date: October 16, 2015; Published date: October 25, 2015
Citation: Kim EK, Kim EA, Kim EH, Kim NH, Choi DH, et al. (2015) Day 4 Biopsy Improves Pregnancy Outcome Comparing to Day 3 Biopsy in Preimplantation Genetic Screening. Gynecol Obstet (Sunnyvale) 5:330. doi:10.4172/2161-0932.1000330
Copyright: © 2015 Kim EK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Aim: Preimplantation genetic screening (PGS) is a routine procedure performed in many in vitro fertilization (IVF) clinics. Embryo biopsy is an invasive procedure, and it has long been recognised that this procedure can affect the subsequent growth and development of the embryo.
Materials and methods: In total, 38 cycles from 31 couples were included in this study. Day 3 biopsy was performed on 126 embryos of 18 patients; 20 patients chose day 4 biopsy with 150 embryos tested. All specimens were screened on a 24-chromosome comparative genomic hybridization (CGH) array.
Results: Of the embryos subjected to day 3 and day 4 biopsies, 22.2% (28/126) and 28.7% (43/150) were normal, demonstrating that our biopsy system has no obvious detrimental effect on compaction. Embryos were transferred on the mornings of day 4 and day 5. Compared with day 3 biopsy (4/13; 30.8%), the day 4 biopsy (7/16; 43.8%) procedure provides an improved pregnancy rate with embryo transfer in current IVF cycle.